<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet13092</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-13092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Перспективы применения полифенолов у пациентов с бронхиальной астмой на фоне ожирения</article-title><trans-title-group xml:lang="en"><trans-title>Prospects for the use of polyphenols in patients with bronchial asthma and obesity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9640-754X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белоглазов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Beloglazov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Белоглазов Владимир Алексеевич, д.м.н., профессор, кафедра внутренней медицины №2</p><p>295051, Симферополь, бульвар Ленина, д. 5/7</p><p>Scopus Author ID: 7007129056</p></bio><bio xml:lang="en"><p>Vladimir A. Beloglazov, MD, PhD, Professor, Department of Internal Medicine №2</p><p>5/7 Lenin Boulevard street, 295051 Simferopol</p></bio><email xlink:type="simple">biloglazov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5486-7262</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яцков</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yatskov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Яцков Игорь Анатольевич, к.м.н., кафедра внутренней медицины №2</p><p>295051, Симферополь, бульвар Ленина, д. 5/7</p><p>Scopus Author ID: 57218873902</p></bio><bio xml:lang="en"><p>Igor A. Yatskov, PhD, Department of Internal Medicine №2</p><p>5/7 Lenin Boulevard street, 295051 Simferopol</p></bio><email xlink:type="simple">egermd@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-9549-5477</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Моик</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Moik</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Моик Анастасия Андреевна, кафедра внутренней медицины №2</p><p>295051, Симферополь, бульвар Ленина, д. 5/7</p></bio><bio xml:lang="en"><p>Anastasia A. Moik, Department of Internal Medicine №2</p><p>5/7 Lenin Boulevard street, 295051 Simferopol</p></bio><email xlink:type="simple">asyabublik2000@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-2467-8435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Моик</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Moik</surname><given-names>Andrey Vladimirovich</given-names></name></name-alternatives><bio xml:lang="ru"><p>Моик Андрей Владимирович, кафедра внутренней медицины №2</p><p>295051, Симферополь, бульвар Ленина, д. 5/7</p></bio><bio xml:lang="en"><p>Andrey V. Moik, Department of Internal Medicine №2</p><p>5/7 Lenin Boulevard street, 295051 Simferopol</p></bio><email xlink:type="simple">dartbatman5@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>«Ордена Трудового Красного Знамени медицинский институт им. С.И. Георгиевского»; ФГАОУ ВО «Крымский федеральный университет имени В.И. Вернадского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Order of the Red Banner of Labor S.I. Georgievsky Medical Institute V.I. Vernadsky Crimean Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>«Ордена Трудового Красного Знамени медицинский институт им. С.И. Георгиевского»; ФГАОУ ВО «Крымский федеральный университет имени В.И. Вернадского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Order of the Red Banner of Labor S. I. Georgievsky Medical Institute V. I. Vernadsky Crimean Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>06</month><year>2024</year></pub-date><volume>21</volume><issue>4</issue><fpage>357</fpage><lpage>364</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Белоглазов В.А., Яцков И.А., Моик А.А., Моик А.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Белоглазов В.А., Яцков И.А., Моик А.А., Моик А.В.</copyright-holder><copyright-holder xml:lang="en">Beloglazov V.A., Yatskov I.A., Moik A.A., Moik A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/13092">https://www.omet-endojournals.ru/jour/article/view/13092</self-uri><abstract><p>Бронхиальная астма (БА) и ожирение представляют собой заболевания, характеризующиеся вариабельностью течения и возможных осложнений, частота встречаемости которых растет из года в год. Взаимосвязь ожирения и БА до сих пор остается актуальной проблемой системы здравоохранения. Представляя собой весьма распространенные заболевания, они утяжеляют течение друг друга и значительно ухудшают качество жизни. Полифенолы — подающий надежды вариант для решения имеющейся проблемы. Данные низкомолекулярные соединения представляют собой биологически активные вещества, способные воздействовать на многие метаболические процессы в организме. В представленном обзоре продемонстрированы множественные свойства этих уникальных микронутриентов, в том числе антиоксидантные, антиканцерогенные, противовоспалительные, метаболические, нейропротективные и многие другие. Внедрение полифенолов в ежедневный рацион может поспособствовать укреплению общественного здоровья, снижению частоты и прогрессирования социально-значимых заболеваний, а применяя данные соединения при таких заболеваниях, как бронхиальная астма и ожирение, согласно многочисленным современным исследованиям, и вовсе удается добиться выраженного терапевтического эффекта. Цель данного литературного обзора — проследить связь между эффектом применения полифенолов и изменением течения заболевания и качества жизни у пациентов с бронхиальной астмой на фоне ожирения, опираясь на данные современных источников</p></abstract><trans-abstract xml:lang="en"><p>Asthma and obesity are diseases characterized by variability in the course and possible complications, the frequency of which is steadily increasing from year to year. The correlation between obesity and asthma is still an acute problem of the health care system. Representing very common diseases, they aggravate each other’s course and significantly worsen the quality of life. Polyphenols are a promising option to solve the existing problem. These low molecular weight compounds are biologically active substances capable of influencing on many metabolic processes in the body. This review demonstrates the multiple properties of these unique micronutrients, including antioxidant, anti-carcinogenic, anti-inflammatory, metabolic, neuroprotective and many others. The integration of polyphenols into the daily diet can contribute to strengthening public health, reducing the frequency and progression of socially significant diseases, and using these compounds in diseases such as asthma and obesity, according to numerous modern studies, it is possible to achieve a significant therapeutic effect at all. The purpose of this literature review is to trace the correlation between the effect of using polyphenols and changes in the course of the disease and quality of life in patients with asthma on the background of obesity, based on facts from advanced sources.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>ожирение</kwd><kwd>полифенолы</kwd><kwd>воспаление</kwd><kwd>аллергия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>asthma</kwd><kwd>obesity</kwd><kwd>polyphenols</kwd><kwd>inflammation</kwd><kwd>allergies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. Available from: www.ginasthma.org</mixed-citation><mixed-citation xml:lang="en">Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. Available from: www.ginasthma.org</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. The Lancet. 2024. doi: https://doi.org/10.1016/S0140-6736(23)02750-2</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population representative studies with 222 million children, adolescents, and adults. The Lancet. 2024. doi: https://doi.org/10.1016/S0140-6736(23)02750-2</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кытикова О.Ю., Новгородцева Т.П., Антонюк М.В. и др. Роль нейротрофических факторов роста в патофизиологии бронхиальной астмы, сочетанной с ожирением // Бюллетень Сибирской Медицины. — 2021. — Т. 20. — №1. — С. 158–167. doi: https://doi.org/10.20538/1682-0363-2021-1-158-167</mixed-citation><mixed-citation xml:lang="en">Kytikova OYu, Novgorodtseva P., Antonyuk MV, et al. The role of neurotrophic growth factors in the pathophysiology of bronchial asthma associated with obesity. Bulletin of Siberian Medicine. 2021;20 (1):158–167. (In Russ.). doi: https://doi.org/10.20538/1682-0363-2021-1-158-167</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Патракеева В.П., Штаборов В.А. Роль питания и состояния микрофлоры кишечника в формировании метаболического синдрома // Ожирение и метаболизм. — 2022. — Т. 19. — №3. — С. 292-299. doi: https://doi.org/10.14341/omet12893</mixed-citation><mixed-citation xml:lang="en">Patrakeeva VP, Shtaborov VA. Nutrition and the state of the intestinal microflora in the formation of the metabolic syndrome. Obesity and metabolism. 2022;19(3):292-299. (In Russ.) doi: https://doi.org/10.14341/omet12893</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yahfoufi N, Alsadi N, Jambi M, et al. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients. 2018;10(11):1618. doi: https://doi.org/10.3390/nu10111618.</mixed-citation><mixed-citation xml:lang="en">Yahfoufi N, Alsadi N, Jambi M, et al. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients. 2018;10(11):1618. doi: https://doi.org/10.3390/nu10111618.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cao Y, Han S, Lu H, et al. Targeting mTOR Signaling by Dietary Polyphenols in Obesity Prevention. Nutrients. 2022;14(23):5171. doi: https://doi.org/10.3390/nu14235171</mixed-citation><mixed-citation xml:lang="en">Cao Y, Han S, Lu H, et al. Targeting mTOR Signaling by Dietary Polyphenols in Obesity Prevention. Nutrients. 2022;14(23):5171. doi: https://doi.org/10.3390/nu14235171</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Castro-Barquero S, Lamuela-Raventós RM, Doménech M, et al. Relationship between Mediterranean Dietary Polyphenol Intake and Obesity. Nutrients. 2018;10(10):1523-1535. doi: https://doi.org/10.3390/nu10101523</mixed-citation><mixed-citation xml:lang="en">Castro-Barquero S, Lamuela-Raventós RM, Doménech M, et al. Relationship between Mediterranean Dietary Polyphenol Intake and Obesity. Nutrients. 2018;10(10):1523-1535. doi: https://doi.org/10.3390/nu10101523</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бобрышева Т.Н., Анисимов Г.С., Золоторева М.С. и др. Полифенолы как перспективные биологически активные соединения // Вопросы питания. — 2023. — Т. 92. — №1. — С. 92-107. doi: https://doi.org/10.33029/0042-8833-2023-92-1-92-107</mixed-citation><mixed-citation xml:lang="en">Bobrysheva TN, Anisimov GS, Zolotoreva MS, et al. Polyphenols as promising bioactive compounds // Voprosy pitaniia. 2023;92(1):92-107. (In Russ.) doi: https://doi.org/10.33029/0042-8833-2023-92-1-92-107</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Miethe S, Karsonova A, Karaulov A, et al. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685-693. doi: https://doi.org/10.1016/j.jaci.2020.08.011</mixed-citation><mixed-citation xml:lang="en">Miethe S, Karsonova A, Karaulov A, et al. Obesity and asthma. J Allergy Clin Immunol. 2020;146(4):685-693. doi: https://doi.org/10.1016/j.jaci.2020.08.011</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Maniscalco M, Paris D, Melck DJ, et al. Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype. J Allergy Clin Immunol. 2017;139(5):1536-1547. doi: https://doi.org/10.1016/j.jaci.2016.08.038.</mixed-citation><mixed-citation xml:lang="en">Maniscalco M, Paris D, Melck DJ, et al. Coexistence of obesity and asthma determines a distinct respiratory metabolic phenotype. J Allergy Clin Immunol. 2017;139(5):1536-1547. doi: https://doi.org/10.1016/j.jaci.2016.08.038.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Haneen SD, Martin CM. Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes? Biomolecules. 2023;13(12):1714. doi: https://doi.org/10.3390/biom13121714</mixed-citation><mixed-citation xml:lang="en">Haneen SD, Martin CM. Is the β3-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes? Biomolecules. 2023;13(12):1714. doi: https://doi.org/10.3390/biom13121714</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Aditya SL, Ryota O, Tomoya H, et al. Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes. Front Med (Lausanne). 2024;11:1305638. doi: https://doi.org/10.3389/fmed.2024.1305638</mixed-citation><mixed-citation xml:lang="en">Aditya SL, Ryota O, Tomoya H, et al. Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes. Front Med (Lausanne). 2024;11:1305638. doi: https://doi.org/10.3389/fmed.2024.1305638</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nikos S, Erika G, Aruna C, et al. The Role of Childhood Asthma in Obesity Development: A Nationwide US Multicohort Study. Epidemiology. 2022;33(1):131-140. doi: https://doi.org/10.1097/EDE.0000000000001421</mixed-citation><mixed-citation xml:lang="en">Nikos S, Erika G, Aruna C, et al. The Role of Childhood Asthma in Obesity Development: A Nationwide US Multicohort Study. Epidemiology. 2022;33(1):131-140. doi: https://doi.org/10.1097/EDE.0000000000001421</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Contreras ZA, Chen Z, Roumeliotaki T, et al. Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts. Eur Respir J. 2018;52(3):1800504. doi: https://doi.org/10.1183/13993003.00504-2018</mixed-citation><mixed-citation xml:lang="en">Contreras ZA, Chen Z, Roumeliotaki T, et al. Does early onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts. Eur Respir J. 2018;52(3):1800504. doi: https://doi.org/10.1183/13993003.00504-2018</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Luiz HCV, Sarah RDF, Maria da CCS, et al. Uncovering the Role of Oxidative Imbalance in the Development and Progression of Bronchial Asthma. Oxid Med Cell Longev. 2021;6692110. doi: https://doi.org/10.1155/2021/6692110</mixed-citation><mixed-citation xml:lang="en">Luiz HCV, Sarah RDF, Maria da CCS, et al. Uncovering the Role of Oxidative Imbalance in the Development and Progression of Bronchial Asthma. Oxid Med Cell Longev. 2021;6692110. doi: https://doi.org/10.1155/2021/6692110</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ito T, Kubo M, Nagaoka K, et al. Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice. J Physiol Biochem. 2018;74(1):9-16. doi: https://doi.org/10.1007/s13105-017-0597-6</mixed-citation><mixed-citation xml:lang="en">Ito T, Kubo M, Nagaoka K, et al. Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice. J Physiol Biochem. 2018;74(1):9-16. doi: https://doi.org/10.1007/s13105-017-0597-6</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Khramova RN, Tush EV, Khramov AA, et al. Relationship of Nutritional Status and Spirometric Parameters in Children with Bronchial Asthma. Sovrem Tekhnologii Med. 2021;12(3):12-23. doi: https://doi.org/10.17691/stm2020.12.3.02</mixed-citation><mixed-citation xml:lang="en">Khramova RN, Tush EV, Khramov AA, et al. Relationship of Nutritional Status and Spirometric Parameters in Children with Bronchial Asthma. Sovrem Tekhnologii Med. 2021;12(3):12-23. doi: https://doi.org/10.17691/stm2020.12.3.02</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Reyes-Angel J, Kaviany P, Rastogi D, et al. Obesityrelated asthma in children and adolescents. Lancet Child Adolesc Health. 2022;6(10):713-724. doi: https://doi.org/10.1016/S2352-4642(22)00185-7</mixed-citation><mixed-citation xml:lang="en">Reyes-Angel J, Kaviany P, Rastogi D, et al. Obesityrelated asthma in children and adolescents. Lancet Child Adolesc Health. 2022;6(10):713-724. doi: https://doi.org/10.1016/S2352-4642(22)00185-7</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Dixon AE, Que LQ. Obesity and Asthma. Semin Respir Crit Care Med. 2022;43(5):662-674. doi: https://doi.org/10.1055/s-0042-1742384</mixed-citation><mixed-citation xml:lang="en">Dixon AE, Que LQ. Obesity and Asthma. Semin Respir Crit Care Med. 2022;43(5):662-674. doi: https://doi.org/10.1055/s-0042-1742384</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Alhammad SA, Alwadeai KS. All Types Obesity and Physical Inactivity Associated with the Risk of Activity of Daily Living Limitations Among People with Asthma. J Multidiscip Healthc. 2022;15:1573-1583. doi: https://doi.org/10.2147/JMDH.S368660</mixed-citation><mixed-citation xml:lang="en">Alhammad SA, Alwadeai KS. All Types Obesity and Physical Inactivity Associated with the Risk of Activity of Daily Living Limitations Among People with Asthma. J Multidiscip Healthc. 2022;15:1573-1583. doi: https://doi.org/10.2147/JMDH.S368660</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dzah CS, Asante-Donyinah D, Letsyo E, et al. Dietary Polyphenols and Obesity: A Review of Polyphenol Effects on Lipid and Glucose Metabolism, Mitochondrial Homeostasis, and Starch Digestibility and Absorption. Plant Foods Hum Nutr. 2023;78(1):1-12. doi: https://doi.org/10.1007/s11130-022-01034-6</mixed-citation><mixed-citation xml:lang="en">Dzah CS, Asante-Donyinah D, Letsyo E, et al. Dietary Polyphenols and Obesity: A Review of Polyphenol Effects on Lipid and Glucose Metabolism, Mitochondrial Homeostasis, and Starch Digestibility and Absorption. Plant Foods Hum Nutr. 2023;78(1):1-12. doi: https://doi.org/10.1007/s11130-022-01034-6</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ohishi T, Fukutomi R, Shoji Y, et al. The beneficial effects of principal polyphenols from green tea, coffee, wine, and curry on obesity. Molecules. 2021;26(2):453-474. doi: https://doi.org/10.3390/molecules26020453</mixed-citation><mixed-citation xml:lang="en">Ohishi T, Fukutomi R, Shoji Y, et al. The beneficial effects of principal polyphenols from green tea, coffee, wine, and curry on obesity. Molecules. 2021;26(2):453-474. doi: https://doi.org/10.3390/molecules26020453</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">de Araújo FF, de Paulo Farias D, Neri-Numa IA, et al. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2021;338:127535. doi: https://doi.org/10.1016/j.foodchem.2020.127535</mixed-citation><mixed-citation xml:lang="en">de Araújo FF, de Paulo Farias D, Neri-Numa IA, et al. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2021;338:127535. doi: https://doi.org/10.1016/j.foodchem.2020.127535</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Xu H, Zhong X, Wang T, et al. (-)-Epigallocatechin-3-Gallate Reduces Perfluorodecanoic Acid-Exacerbated Adiposity and Hepatic Lipid Accumulation in High-Fat Diet-Fed Male C57BL/6J Mice. Molecules. 2023;28(23):7832. doi: https://doi.org/10.3390/molecules28237832</mixed-citation><mixed-citation xml:lang="en">Xu H, Zhong X, Wang T, et al. (-)-Epigallocatechin-3-Gallate Reduces Perfluorodecanoic Acid-Exacerbated Adiposity and Hepatic Lipid Accumulation in High-Fat Diet-Fed Male C57BL/6J Mice. Molecules. 2023;28(23):7832. doi: https://doi.org/10.3390/molecules28237832</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Oruganti L, Reddy Sankaran K, Dinnupati HG, et al. Anti-adipogenic and lipid-lowering activity of piperine and epigallocatechin gallate in 3T3-L1 adipocytes. Arch Physiol Biochem. 2023;129(5):1152-1159. doi: https://doi.org/10.1080/13813455.2021.1908366</mixed-citation><mixed-citation xml:lang="en">Oruganti L, Reddy Sankaran K, Dinnupati HG, et al. Anti-adipogenic and lipid-lowering activity of piperine and epigallocatechin gallate in 3T3-L1 adipocytes. Arch Physiol Biochem. 2023;129(5):1152-1159. doi: https://doi.org/10.1080/13813455.2021.1908366</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ngamsamer С, Sirivarasai J, Sutjarit N. The Benefits of Anthocyanins against Obesity-Induced Inflammation. Biomolecules. 2022;12(6):852. doi: https://doi.org/10.3390/biom12060852</mixed-citation><mixed-citation xml:lang="en">Ngamsamer С, Sirivarasai J, Sutjarit N. The Benefits of Anthocyanins against Obesity-Induced Inflammation. Biomolecules. 2022;12(6):852. doi: https://doi.org/10.3390/biom12060852</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ohmae S, Akazawa S, Takahashi T, et al. Quercetin attenuates adipogenesis and fibrosis in human skeletal muscle. Biochem Biophys Res Commun. 2022;615:24-30. doi: https://doi.org/10.1016/j.bbrc.2022.05.033</mixed-citation><mixed-citation xml:lang="en">Ohmae S, Akazawa S, Takahashi T, et al. Quercetin attenuates adipogenesis and fibrosis in human skeletal muscle. Biochem Biophys Res Commun. 2022;615:24-30. doi: https://doi.org/10.1016/j.bbrc.2022.05.033</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Suh JH, Wang Y, Ho C-T. Natural dietary products and their effects on appetite control. J Agric Food Chem. 2018;66(1):36-39. doi: https://doi.org/10.1021/acs.jafc.7b05104</mixed-citation><mixed-citation xml:lang="en">Suh JH, Wang Y, Ho C-T. Natural dietary products and their effects on appetite control. J Agric Food Chem. 2018;66(1):36-39. doi: https://doi.org/10.1021/acs.jafc.7b05104</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gowd V, Karim N, Shishir MRI, et al. Dietary polyphenols to combat the metabolic diseases via altering gut microbiota. Trends in Food Science &amp; Technology. 2019;93:81-93. doi: https://doi.org/10.1016/j.tifs.2019.09.005</mixed-citation><mixed-citation xml:lang="en">Gowd V, Karim N, Shishir MRI, et al. Dietary polyphenols to combat the metabolic diseases via altering gut microbiota. Trends in Food Science &amp; Technology. 2019;93:81-93. doi: https://doi.org/10.1016/j.tifs.2019.09.005</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sousa JN, Paraíso AF, Andrade J, et al. Oral gallic acid improve liver steatosis and metabolism modulating hepatic lipogenic markers in obese mice. Exp Gerontol. 2020;134(10):110881. doi: https://doi.org/10.1016/j.exger.2020.110881</mixed-citation><mixed-citation xml:lang="en">Sousa JN, Paraíso AF, Andrade J, et al. Oral gallic acid improve liver steatosis and metabolism modulating hepatic lipogenic markers in obese mice. Exp Gerontol. 2020;134(10):110881. doi: https://doi.org/10.1016/j.exger.2020.110881</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">He X, Zheng S, Sheng Y, et al. Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice. J Sci Food Agric. 2021;101(2):631-637. doi: https://doi.org/10.1002/jsfa.10675</mixed-citation><mixed-citation xml:lang="en">He X, Zheng S, Sheng Y, et al. Chlorogenic acid ameliorates obesity by preventing energy balance shift in high-fat diet induced obese mice. J Sci Food Agric. 2021;101(2):631-637. doi: https://doi.org/10.1002/jsfa.10675</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Q, Wang Y, Han X, et al. Efficacy of resveratrol supplementation on glucose and lipid metabolism: A metaanalysis and systematic review. Front Physiol. 2022;13:795980. doi: https://doi.org/10.3389/fphys.2022.795980</mixed-citation><mixed-citation xml:lang="en">Zhou Q, Wang Y, Han X, et al. Efficacy of resveratrol supplementation on glucose and lipid metabolism: A metaanalysis and systematic review. Front Physiol. 2022;13:795980. doi: https://doi.org/10.3389/fphys.2022.795980</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Q, Zhang S, Gao X, et al. Resveratrol Inhibits Proliferation and Differentiation of Porcine Preadipocytes by a Novel LincRNAROFM/ miR-133b/AdipoQ Pathway. Foods. 2022;11(17):2690. doi: https://doi.org/10.3390/foods11172690</mixed-citation><mixed-citation xml:lang="en">Jiang Q, Zhang S, Gao X, et al. Resveratrol Inhibits Proliferation and Differentiation of Porcine Preadipocytes by a Novel LincRNAROFM/ miR-133b/AdipoQ Pathway. Foods. 2022;11(17):2690. doi: https://doi.org/10.3390/foods11172690</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Koundouros N, Blenis J. Targeting mTOR in the Context of Diet and Whole-body Metabolism. Endocrinology. 2022;163(6):bqac041. doi: https://doi.org/10.1210/endocr/bqac041</mixed-citation><mixed-citation xml:lang="en">Koundouros N, Blenis J. Targeting mTOR in the Context of Diet and Whole-body Metabolism. Endocrinology. 2022;163(6):bqac041. doi: https://doi.org/10.1210/endocr/bqac041</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101(3):1371–1426. doi: https://doi.org/10.1152/physrev.00026.2020</mixed-citation><mixed-citation xml:lang="en">Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101(3):1371–1426. doi: https://doi.org/10.1152/physrev.00026.2020</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cani PD, Van Hul M, Lefort C, et al. Microbial regulation of organismal energy homeostasis. Nat Metab. 2019;1(1):34-36. doi: https://doi.org/10.1038/s42255-018-0017-4</mixed-citation><mixed-citation xml:lang="en">Cani PD, Van Hul M, Lefort C, et al. Microbial regulation of organismal energy homeostasis. Nat Metab. 2019;1(1):34-36. doi: https://doi.org/10.1038/s42255-018-0017-4</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Chávez-Carbajal A, Nirmalkar K, Pérez-Lizaur A, et al. Gut microbiota and predicted metabolic pathways in a sample of mexican women affected by obesity and obesity plus metabolic syndrome. Int J Mol Sci. 2019;20(2):438. doi: https://doi.org/10.3390/ijms20020438</mixed-citation><mixed-citation xml:lang="en">Chávez-Carbajal A, Nirmalkar K, Pérez-Lizaur A, et al. Gut microbiota and predicted metabolic pathways in a sample of mexican women affected by obesity and obesity plus metabolic syndrome. Int J Mol Sci. 2019;20(2):438. doi: https://doi.org/10.3390/ijms20020438</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mulders RJ, de Git KCG, Schéle E, et al. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes Rev. 2018;19(4):435-451. doi: https://doi.org/10.1111/obr.12661</mixed-citation><mixed-citation xml:lang="en">Mulders RJ, de Git KCG, Schéle E, et al. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obes Rev. 2018;19(4):435-451. doi: https://doi.org/10.1111/obr.12661</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Corrêa TAF, Rogero MM, Hassimotto NMA, et al. The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. Front Nutr. 2019;6:188. doi: https://doi.org/10.3389/fnut.2019.00188</mixed-citation><mixed-citation xml:lang="en">Corrêa TAF, Rogero MM, Hassimotto NMA, et al. The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. Front Nutr. 2019;6:188. doi: https://doi.org/10.3389/fnut.2019.00188</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12(1):35. doi: https://doi.org/10.1038/s41387-022-00213-3</mixed-citation><mixed-citation xml:lang="en">Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12(1):35. doi: https://doi.org/10.1038/s41387-022-00213-3</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Leis K, Gałazka P, Kazik J, et al. Resveratrol in the treatment of asthma based on an animal model. Postepy Dermatol Alergol. 2022;39(3):433-438. doi: https://doi.org/10.5114/ada.2022.117543</mixed-citation><mixed-citation xml:lang="en">Leis K, Gałazka P, Kazik J, et al. Resveratrol in the treatment of asthma based on an animal model. Postepy Dermatol Alergol. 2022;39(3):433-438. doi: https://doi.org/10.5114/ada.2022.117543</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Chauhan PS, Jaiswal A, Subhashini, et al. Combination Therapy with Curcumin Alone Plus Piperine Ameliorates Ovalbumin-Induced Chronic Asthma in Mice. Inflammation. 2018;41(5):1922-1933. doi: https://doi.org/10.1007/s10753-018-0836-1</mixed-citation><mixed-citation xml:lang="en">Chauhan PS, Jaiswal A, Subhashini, et al. Combination Therapy with Curcumin Alone Plus Piperine Ameliorates Ovalbumin-Induced Chronic Asthma in Mice. Inflammation. 2018;41(5):1922-1933. doi: https://doi.org/10.1007/s10753-018-0836-1</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Das A, Pathak MP, Pathak K, et al. Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review. Front Pharmacol. 2023;14:1186060. doi: https://doi.org/10.3389/fphar.2023.1186060</mixed-citation><mixed-citation xml:lang="en">Das A, Pathak MP, Pathak K, et al. Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review. Front Pharmacol. 2023;14:1186060. doi: https://doi.org/10.3389/fphar.2023.1186060</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hosawi S. Current Update on Role of Hesperidin in Inflammatory Lung Diseases: Chemistry, Pharmacology, and Drug Delivery Approaches. Life (Basel). 2023;13(4):937. doi: https://doi.org/10.3390/life13040937</mixed-citation><mixed-citation xml:lang="en">Hosawi S. Current Update on Role of Hesperidin in Inflammatory Lung Diseases: Chemistry, Pharmacology, and Drug Delivery Approaches. Life (Basel). 2023;13(4):937. doi: https://doi.org/10.3390/life13040937</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Muhammad H, Salahuddin Z, Akhtar T, et al. Immunomodulatory effect of glabridin in ovalbumin induced allergic asthma and its comparison with methylprednisolone in a preclinical rodent model. J Cell Biochem. 2023;124(10):1503-1515. doi: https://doi.org/10.1002/jcb.30459</mixed-citation><mixed-citation xml:lang="en">Muhammad H, Salahuddin Z, Akhtar T, et al. Immunomodulatory effect of glabridin in ovalbumin induced allergic asthma and its comparison with methylprednisolone in a preclinical rodent model. J Cell Biochem. 2023;124(10):1503-1515. doi: https://doi.org/10.1002/jcb.30459</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Yang N, Shang YX. Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model. Int Immunopharmacol. 2019;72(3):422-428. doi: https://doi.org/10.1016/j.intimp.2019.04.044</mixed-citation><mixed-citation xml:lang="en">Yang N, Shang YX. Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model. Int Immunopharmacol. 2019;72(3):422-428. doi: https://doi.org/10.1016/j.intimp.2019.04.044</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Dębinska A, Sozanska B. Dietary Polyphenols-Natural Bioactive Compounds with Potential for Preventing and Treating Some Allergic Conditions. Nutrients. 2023;15(22):4823. doi: https://doi.org/10.3390/nu15224823</mixed-citation><mixed-citation xml:lang="en">Dębinska A, Sozanska B. Dietary Polyphenols-Natural Bioactive Compounds with Potential for Preventing and Treating Some Allergic Conditions. Nutrients. 2023;15(22):4823. doi: https://doi.org/10.3390/nu15224823</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Kim CY, Kim JW, Kim JH, et al. Inner shell of the chestnut (Castanea crenatta) suppresses inflammatory responses in ovalbumin-induced allergic asthma mouse model. Nutrients. 2022;14(10):2067. doi: https://doi.org/10.3390/nu14102067</mixed-citation><mixed-citation xml:lang="en">Kim CY, Kim JW, Kim JH, et al. Inner shell of the chestnut (Castanea crenatta) suppresses inflammatory responses in ovalbumin-induced allergic asthma mouse model. Nutrients. 2022;14(10):2067. doi: https://doi.org/10.3390/nu14102067</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Huang Q, Han L, Lv R, et al. Magnolol exerts anti-asthmatic effects by regulating Janus kinase-signal transduction and activation of transcription and Notch signaling pathways and modulating Th1/Th2/Th17 cytokines in ovalbumin-sensitized asthmatic mice. Korean J Physiol Pharmacol. 2019;23(4):251-261. doi: https://doi.org/10.4196/kjpp.2019.23.4.251</mixed-citation><mixed-citation xml:lang="en">Huang Q, Han L, Lv R, et al. Magnolol exerts anti-asthmatic effects by regulating Janus kinase-signal transduction and activation of transcription and Notch signaling pathways and modulating Th1/Th2/Th17 cytokines in ovalbumin-sensitized asthmatic mice. Korean J Physiol Pharmacol. 2019;23(4):251-261. doi: https://doi.org/10.4196/kjpp.2019.23.4.251</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Jafarinia M, Hosseini MS, Kasiri N, et al. Quercetin with the potential effect on allergic diseases. Allergy Asthma Clin Immunol. 2020;16:36. doi: https://doi.org/10.1186/s13223-020-00434-0</mixed-citation><mixed-citation xml:lang="en">Jafarinia M, Hosseini MS, Kasiri N, et al. Quercetin with the potential effect on allergic diseases. Allergy Asthma Clin Immunol. 2020;16:36. doi: https://doi.org/10.1186/s13223-020-00434-0</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
